OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 75 filers reported holding OPHTHOTECH CORP in Q1 2014. The put-call ratio across all filers is 8.25 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,000 | -50.0% | 705 | -47.0% | 0.00% | – |
| Q4 2018 | $2,000 | -60.0% | 1,329 | -40.7% | 0.00% | – |
| Q3 2018 | $5,000 | -64.3% | 2,243 | -56.7% | 0.00% | – |
| Q2 2018 | $14,000 | -85.6% | 5,182 | -85.3% | 0.00% | – |
| Q1 2018 | $97,000 | -43.9% | 35,359 | -36.1% | 0.00% | – |
| Q4 2017 | $173,000 | +8.8% | 55,353 | -1.6% | 0.00% | – |
| Q3 2017 | $159,000 | +12.0% | 56,258 | +1.4% | 0.00% | – |
| Q2 2017 | $142,000 | +42.0% | 55,461 | +102.3% | 0.00% | – |
| Q1 2017 | $100,000 | -75.3% | 27,421 | +174.2% | 0.00% | -100.0% |
| Q3 2015 | $405,000 | -22.3% | 10,000 | 0.0% | 0.00% | -50.0% |
| Q2 2015 | $521,000 | -46.9% | 10,000 | -52.6% | 0.00% | -33.3% |
| Q1 2015 | $982,000 | -23.9% | 21,108 | -26.6% | 0.00% | -25.0% |
| Q4 2014 | $1,290,000 | +154.9% | 28,738 | +121.1% | 0.00% | +100.0% |
| Q3 2014 | $506,000 | -40.2% | 13,000 | -35.0% | 0.00% | -33.3% |
| Q2 2014 | $846,000 | +57.8% | 20,000 | +33.3% | 0.00% | +50.0% |
| Q1 2014 | $536,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
| Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
| JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
| AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
| Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
| IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
| WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
| Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
| Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |